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ABSTRACT 
Background and aims: Orthodontic appliances serve as different impact zones and modify microbial 
adherence and colonization, acting as foreign reserves and possible sources of infection. This study was 
conducted to investigate the effect of fixed orthodontic appliances introduction on the growth and 
adherence (biofilm formation) of Candida species. And also determine the species distribution, and 
antifungal sensitivity to isolated Candida. Material and methods: The investigational group was selected  
from  orthodontic patients whom were examined clinically as soon as to get baseline information before 
active treatment.  The cluster included 210 patients; 45 males, 165 females (mean age 21.6 ± 4.5 years).  
Clinical, demographic data and risk factors were collected in standard questionnaire then each individual  
was directed to carry out oral wash by a phosphate-buffered saline solution, which was expectorated and 
processed intended for the isolation and identification of Candida species by standard methods. After that 
the isolated Candida species were tested for biofilm production by the phenotypic method i.e. Tissue 
culture palate methods (TCPM). Finally, antibiogram susceptibility pattern of oral Candida species was 
done by Kirby-Bauer disc diffusion method for amphotericin B, ketoconazole, and fluconazole.  Results: 
The most common yeast colonized oral cavity after the introduction of FOA was C. albicans (72.5%), 
followed by C. glabrata  and C. tropicalis  (12.5%) , while Candida parapsilosis  only was 2.5%.  The rate 
of formation of biofilms was 52.5% for all types of Candida, and it was found that biofilm formation 
occurs more frequently among C.tropicals and  C. glabrata  (60%)  than C. albicans (48.3%). All candida 
species isolates were sensitive to amphotericin B and ketoconazole while resistance to fluconazole was 
found in 40% of C. tropicalis   and 20% in C. glabrata  and 13.8% in C. albicans.  Conclusion: The 
present study proved that C. albicans is still the major isolate from oral cavity after the introduction of 
FOA, but non-albicans species colonization is raised and FOA might be factor for biofilm formation. The 
C. tropicalis  and C. glabrata  were more biofilm - producers compared to C. albicans. The species isolated 
in the current study  are less susceptible to fluconazole and drug resistant factor in the Candida species 
isolates was found to be associated with candidal biofilm formation.  
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INTRODUCTION 
For a long time, the conventional orthodontic patient was considered a low-risk patient and the orthodontic 
process was regarded as non-invasive1. Nevertheless, these devices can be associated with difficulty cleaning. 
During treatment, festive areas are created that favor the accumulation of biofilms and bacterial and fungal 
growth 2. One of the biggest challenges in orthodontics is to maintain proper oral hygiene during treatment. , 
bands and other accessories further exacerbate these conditions by retaining the dental plaque, which can lead to 
gingivitis and enamel demineralization, causing white spots, caries and candida stomatitis 3-6. Microbiological 
studies have proven that after setting a fixed orthodontic appliance, the number of microorganisms increases 
significantly, especially streptococci, lactobacilli and Candida, exposing the oral environment to an imbalance 
and allowing the emergence of diseases 2-6. 
Even though dental biofilms are made up of many types of microorganisms, yeast and bacteria are believed to be 
involved in the early development of oral and dental lesions4-7. Therefore, the success of orthodontic treatment 
lies in correcting the occlusion in the best possible way, in spite of this, without affecting the health of the teeth 
and the supporting tissues; unless, the benefits of treatment can be questioned4,5,8. The practice of orthodontics is 
undergoing continuous progress using new techniques and materials that benefit both patients and practitioners9. 
Emphasis has been placed on attempts to prevent the development of carious lesions or oral infections in 
orthodontic patients on controlling bacterial and yeast biofilms around the arcs 3-6. During treatment, 
orthodontists are also responsible for preventing caries and preventing other mouth infections 4-6,8. 
 The orthodontic appliance acts as a different site for the formation of biofilms10. In a study by Eliades and others 
11, stainless steel feet above critical surface tension can be expected to have a higher plaque retaining capacity. 
Also, metal orthodontic brackets have been found to stimulate specific changes in the oral environment such as 
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low pH levels and the affinity of microorganisms to a metal surface due to electrostatic reactions 12, increased 
plaque buildup, and colonization of organisms increased. However, other studies on possible differences in initial 
convergence and adherence to microorganisms on metal, ceramic and plastic brackets over time were 
inconclusive4,5,13,14. Thus, it is difficult to make a clear assessment that metal braces have less carcinogenic effect 
on the teeth or reduce colonization of the mucous membrane than plastic or ceramic braces. Inserting the 
orthodontic wire tends to create new surfaces available to form plaques and thereby increase the level of 
microorganisms in the oral cavity. It has long been suggested that orthodontic bands and wires lead to increased 
plaque buildup and elevated levels of streptococcus, lactobacilli and yeast. Additionally, orthodontic patients 
with fixed devices often offer an abundance of S. mutans per plaque compared to untreated orthodontic patients 
15. As a result, preventing microbial attachment to orthodontic wires is a major concern for orthodontists. 
Candida species are most often recovered  in the mouth, equal to 50% in young adults 5,16,17. Candida 
albicans is the common species; on the other hand other species such as C. parapsilosis, C. dubliniensis, C. 
krusei , C. tropicalis,  and C. glabrata have increased in occurrence with restricted drugs sensitive to them 
including allylamines, polyenes, azoles and echinocandins classes due to the development of drug 
resistance promptly to Candida species4,5. The yeast of the genus Candida, albicans species, has been 
analyzed because it is most common in oral mucosa. It has been proven that this yeast colonizes cement, 
enamel and dentine, and serves as a reservoir for the spread of infection18. However, the ability of yeast to 
remain on inactive surfaces needs further clarification in order to understand its virulence and 
dissemination routes19,20.  This study was conducted to investigate the effect of fixed orthodontic appliances 
introduction on the growth and adherence (biofilm formation) of Candida species. And also determine the 
species distribution, and antifungal sensitivity to isolated Candida. 
SUBJECTS AND LABORATORY METHODS 
 Subject Selection 
A total of two hundred and ten people were included, during FOA treatment, who were randomly selected 
from Al-Thawra Hospital, Al-Gomhoria Hospital, Faculty of dentistry Sana’a and IBB University clinics 
and Dental Centers in Sana’a and IBB; including Alhasani clinic and Dental Center in IBB City, Yemen. 
The duration of the study was six months period, started in August 2019 and ended in February 2020. 
Inclusion criteria for subject selection were healthy individuals with no clinical signs of Candida infection 
and no systemic disease. In addition, individuals who currently taking antifungal, steroids, antibiotics, or 
immunosuppressive drugs in the past 6 months were excluded.  
 Collection and identification of samples: Saliva samples were collected using the oral rinse technique. In 
summary, each subject was required to rinse the mouth for 60 seconds using 10 mL of a phosphate sterile 
saline (PBS, 0.01M phosphate buffered saline, pH 7.2) and eject the rinse into a sterile 15 mL container21.  
The samples were immediately transported on ice to the microbiology laboratory. Each oral rinse was 
centrifuged at 3500 rpm for 10 minutes, and then the supernatant was discarded. The pellet was re-
suspended in 1ml sterile PBS. One hundred µl of the concentrated oral rinse was inoculated onto 
Sabouraud’s dextrose agar and incubated at 37 oC for 48 hours. The lasting samples were stored at -20o C. 
If Candida colonies appeared on the Sabouraud’s dextrose agar, then chromogenic Candida agar was 
inoculated using 100µl of the oral rinse supernatant and incubated for 48 hours for colonies study. Candida 
species were identified by the color of the colonies using the color reference guide supplied by the 
manufacturer. When color identification was unclear, fermentation assay of sucrose, maltose, glucose, 
lactose and galactose was done. The Candida species were also identified by the ability to produce 
chlamydo-spores on glutinous rice agar22.  
Antifungal Susceptibility Testing 
The in vitro activity of antifungal agents (amphotericin B, ketoconazole, and fluconazole) was measured by 
disk diffusion method according to the procedure described in the clinical and laboratory standard institute 
22. The plates were incubated at 35°C, and inhibition zone diameters (dz)were measured after 24 and 48 h 
particularly for C. glabrata. The interpretive criteria for the disk test were as follow: amphotericin B: dz 
≥15mm, susceptible; 14≥dz≥10mm, susceptible dose dependent and dz≤9mm, resistant. Fluconazole: dz 
≥19mm, susceptible; 15≤dz≤18mm, susceptible dose dependent and dz≤14mm, resistant. As for 
ketoconazole: dz≥20mm, susceptible; 10<dz susceptible dose dependent and dz≤10mm, resistant 23.  
Biofilm production detection  
The detection of biofilm was done by tissue culture method/microtiter plate method (TCA)24,25. The yeast  
isolates from fresh agar plates were inoculated in 2 ml of BHI broth and incubated for 24 h at 37°C. The 
cultures were then diluted 1:40 with fresh medium (BHI broth supplemented with 1% glucose); 200 μl of 
the sample was dispensed in the individual microtitration plate and incubated further 24 h at 37°C. With a 
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gentle tapping, the content was removed further with a subsequent washing with phosphate buffer saline 
(pH 7.2) three times to remove free floating sessile Candida. The adherent yeast, biofilm producer, were 
fixed with sodium acetate (2%) and stained with crystal violet (0.1% w/v) for 10–15 min. The unbound 
crystal violet solution was removed with a triplicate washing with PBS, and the plate, then, was kept for 
drying. Finally, all wells were filled with 200 μl ethanol (95%) to release dye from the well and Optical 
Density (OD) was taken at the wavelength of 630 nm. OD value of each test strain and negative control 
were calculated, and OD cutoff values (ODc) were assessed as described previously25. 
DATA ANALYSIS 
The results were expressed as percentages for the description of Candida isolates according to species and 
various clinical samples. Data were statistically analyzed using the chi-squared test. A value of p < 0.05 
was considered significant. 
ETHICAL APPROVAL  
We obtained written consent from all cases. The study proposal was evaluated and approved by the Ethics 
Committee of Faculty of Medicine and Health Sciences, Sana’a University. 
RESULTS  
   Table 1 shows the age and gender distribution of patients with fixed orthodontics at a selected dental 
clinic in Sana’a. 78.6% of the participants are female and only 21.4% are male. The age average ± SD for 
participants was 21.6 ± 4.5 years. Most of the subjects covered were in the age group 21-25 years (55.7%) 
followed by 16-20 years (29%). Table 2 shows the distribution of different types of Candida species among 
Fixed Orthodontic patients. The predominant isolated Candida species  were C. albicans with a 
significantly improved OCAC rate of 13.8% after the introduction of FOA. Also the rate of Candida 
 glabrata and Candida tropicalis was 2.4% after the introduction of FOA; and  Candida parapsilosis 
isolated from 1 patient (0.5%). 
Out of 40 Candida species tested, 21 (52.5%) were found to be biofilm producers. Maximum biofilm 
production was observed in the current study in C. tropicalis and Candida  glabrata where 3 out of 5 
isolates (60%) showed biofilm production followed by Candida albicans (48.3%). In the present study the 
degree of biofilm was divided from high and moderate to non or weak; C. tropicalis showed 40% ability to 
produce a high level of biofilm formation, while only 17.2% of C. albicans showed that (Table 3). In vitro 
antifungal susceptibilities of various Candida species; showed in our study that all isolates were susceptible 
to amphotericin B and ketoconazole. Fluconazole resistance  was found in 13.8% of candida albicans, 40% 
in C. tropicalis and 20% in  C. glabrata   (Table 4). Biofilm strains showed relatively high resistance 
against Fluconazole 19%  compared to non-producing biofilm strains 5.2% (Table 5). 
 DISCUSSION 
The current study,  explored OCAC rate through fixed orthodontic therapy, indicates that the wearing of such 
appliances leads to enhanced carriage and extensive changes in the oral microorganism population, probably due 
to the appliance-induced ecological alterations within the oral cavity. The OCAC primary absence of the baseline 
patient cluster was not unexpected, as applicants were requested to establish good oral hygiene prior to the trial. 
However, after the introduction of FOA, a 13.8 percent increase in the OCAC rate was observed in the test group. 
The incidence of orthodontic attachments on the labial and lingual surfaces of these teeth is likely to be the cause 
for this observation, as they interfere with thorough brushing of the gingival area. Similar changes in OCAC rate 
during orthodontic treatment with removable and fixed appliances have been reported by several authors4-6. 
Furthermore, the presence of rough-surfaced bonding material in FOA or dentures  acting as a candida albicans  
trap and a gingival irritation 4,16,17,26,27 may have played a causative role.  Thus, a significant increase in the 
OCAC rate after the introduction of FOA in the current study may be partly due to the patient's attitude and 
behavior, in addition to the presence of FOA which made it difficult to maintain dental hygiene. Knowing the 
growth and adhesion of cariogenic streptococci and Candida albicans to orthodontics will highlight a better way 
to prevent the enamel demineralization and the formation of white spots 28. Biofilms are recognized for their 
composition on many implanted medical devices, including catheters, pacemakers, heart valves, dentures, and 
artificial joints, which provide a surface and safe haven for the growth of biofilms 18, 29-31. The human health 
consequences of device -related infection can be severe and very life-threatening32.  
   In the present study, there was a significant oral carriage rate for candida albicans, among FOA patients  
(13.8%). Also, out of 40 Candida species 21 (52.5%) were found to be biofilm producers. This high rate of 
colonization and biofilm production of Candida species in FOA patients may lead to oral infections in our 
individuals or move to the respiratory and digestive systems. This suggestion can be confirmed by NHI analysis 
that indicates that biofilms in general (including bacterial and fungal biofilms) are responsible for more than 80% 
of all microbial infections33. For structural and physiological reasons, the biofilms are inherently resistant to 
antimicrobial therapy and immune defenses of the host. Biofilms cause many infections, ranging from infections 
of the superficial mucosa to severe, diffuse bloodstream infections. These infections are most frequently started  
from biofilms formed on mucosal surfaces or implanted medical devices, such as FOA. 
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    Our study showed that among the non-albicans species, the biofilm positivity occurred most frequently among 
isolates of C. tropicalis (60%), also C. tropicalis showed the highest score of biofilm intensity  40%.  This result 
is similar to several published studies in which C. tropicalis was recognized as strong slime producers 34-36. 
However, Kuhn et al, 37 showed that C. albicans produces quantitatively more biofilm than other Candida 
species, but in that study the assessment of biofilm was based on quantization and fluorescent microscopic 
examination proving that the biofilm formed by pathogenic C. albicans was a complex phenomenon composed of 
blastospore layer coved by a thick biphasic matrix, consisting of a dense extracellular component comprised of 
cell wall-like compounds and abundant hyphal elements composed of polysaccharide elements 37.  
   In the current study, in vitro antifungal sensitivity to various Candida species showed that all isolates were 
sensitive to amphotericin B and ketoconazole. However, resistance to fluconazole was found in 13.8% of 
Candida albicans, 40% in C. tropicalis; and 20% in C. glabrata (Table 4). Also, biofilm strains displayed 
relatively high resistance against tested fluconazole 19% than non biofilm producers 5.2% (Table 5). This result 
can be explained by the facts that Candida biofilms are resistant to standard antifungal medications due to the 
availability of biofilms that are considered physical protection of fungi from medications, as well as cells in 
biofilms become essentially resistant to drugs due to their altered metabolic states and their constitutive up 
regulation of drug pumps 33. C. albicans biofilm development in vitro can be divided into four phases:38-41 (1) 
attachment and colonization of round yeast cells to a surface; (2) growth and proliferation of yeast cells creating a 
basal layer of anchoring cells; (3) growth of pseudohyphae (oval yeast cells joined end to end) and hyphae (long 
cylindrical cells) accompanying the production of the extracellular matrix and; (4) dispersal of cells from the 
biofilm to find new sites to colonize.  
   Our study showed that C. albicans was the predominant species recovered from oral cavity of FOA 
patients. These findings are consistent with those previously reported by other researchers 4-6,44. In a recent 
studies C. albicans was reported as the major agents of stomatitis 5,6. Our data provide evidence that the 
majority of Candida species recovered from the FOA  (biomaterials) have higher capacity to produce 
biofilm. Similar results were obtained by other studies45,46. Kuhn et al, 37 reported that invasive C. albicans 
isolates form more biofilm than noninvasive isolates 37. Candida species are frequently found in the normal 
microbial flora of humans, which facilitates their encounter through implanted biomaterials and host 
surfaces 47.  
   In this study the resistance of all the isolated Candida species to fluconazole was 17.5%. The study by 
Nemati et al 48, and Mohamed and Al-Ahmadey 49 reported that the rate of resistance to fluconazole among 
Candida species ranged from null to the 15% 48,49. Furthermore, our data on the fluconazole against C. 
albicans, revealed that 95% of tested strains were susceptible. This sensitivity rate is more or less 
comparable with those rates of 95%, 87.5% and 89.5% previously reported by Mohamed and Al-Ahmadey 
49, Citak et al, 50 and Badiee and Alborzi 51, respectively. In agreement with the study of Mohamed and Al-
Ahmadey 49 and Sabatelli et al. 52, most of the detected resistant strains belong to non- albicans species  
(25%), emphasizing, its greatest potential to acquire resistance to fluconazole. Also, in agreement with the 
finding of Ng et al 23 who reported, amphotericin B and ketoconazole susceptibility data and showed that 
all yeast isolates were susceptible.  The possibility of increase in the percentage of the resistance to 
antifungal agents among Candida species might be due to widespread use of antifungal drugs, long-term 
use of suppressive azoles, and the use of short courses of antifungal drugs 23. 
CONCLUSION  
The present study proved that C. albicans is still the major isolate from oral cavity of after introducing 
FOA, but non-albicans species colonization is raised; FOA was factor for oral colonization of Candida 
species, and biofilm formation. The C. tropicalis were more biofilm - producers compared to C. albicans. 
The species isolated in the current study  are less susceptible to fluconazole and drug resistant factor in the 
Candida species isolates was found to be associated with candidal biofilm formation.  
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Table 1: The age and sex distribution of patients with fixed orthodontics at a selected dental clinic in the 
city of Sana'a and Ibb. 
 
characters number percentage 
Sex 
Male 45 21.4 
female 165 78.6 
Age groups 
≤15 years 12 5.7 
16-20 years 61 29 
21-25 years 117 55.7 
>25 years 20 9.5 
Total 210 100 
Mean age 21.6 years 
SD 4.5 years 
Median 21 years 
Mode 21 years 
Min 13 years 
Max 25 years 
 
 
Table 2: Distribution of different types of Candida species among Fixed Orthodontic patients. 
 
Candida species Number Rate from 
Total n=210 
Rate from 
total isolates 
n=40 
Candida albicans 29 13.8 72.5 
Candida  glabrata 5 2.4 12.5 
Candida tropicalis 5 2.4 12.5 
Candida parapsilosis 1 0.5 2.5 
Total Candida species 40 19 100 
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Table 3: Biofilm detection by TCP method for different oral Candida species isolates. 
 
 
 
Candia species 
Biofilm detection by TCP  
Total biofilm 
positive High* Moderate* Non/weak* 
No. % No. % No. % No. % 
Candida albicans n=29 
5 17.2 9 31 15 51.7 14 48.3 
Candida  glabrata n=5 
1 20 2 40 2 40 3 60 
Candida tropicalis n=5 
2 40 1 20 2 40 3 60 
Candida parapsilosis n=1 
0 0 1 100 0 0 1 100 
Total n=40 8 20 13 32.5 19 47.5 21 52.5 
TCP-*High-O.D(>0.240), *Moderate-O.D (0.120-0.240), *Weak/Non-O.D (<0.120). 
 
Table 4: In-vitro antifungal susceptibility of oral Candida species isolated  from Fixed Orthodontic 
patients. 
Organisms 
Fluconazole Ketoconazole Amphotracin B 
S (%) R (%) S (%) R (%) 
S (%) R (%) 
Candida albicans n=29   25 (86.2)  4 (13.8)  29 (100) 0 (0)  29(100) 0  (0) 
Candida  glabrata n=5  4 (80)  1 (20) 5 (100) 0 (0)   4(100) 0  (0) 
Candida tropicalis n=5  3(60) 2  (40) 5 (100) 0(0) 5 (100) 0 (0) 
Candida parapsilosis n=1 1  (100) 0(0) 1 (100) 0(0) 1  (100) 0  (0) 
Total n=40 33 (82.5) 7 (17.5) 40 (100) 0 (0) 40 (100) 0 (0) 
 
R= resistant, S= sensitive  
 
Table 5: Antifungal resistance pattern of Candida species associated with biofilm formation in oral 
Candida species isolated from FOA patients 
 
 
P value 
Non-biofilm         
producing Candida 
species 
n=19 
Biofilm producing 
Candida species 
n=21 
Antimicrobial agents 
0.01 1 (5.2%)  4 (19%) Fluconazole 
1.0 0 (0%) 0 (0%) Ketoconazole  
1.0 0 (0%) 0 (0%) Amphotracin B 
 
 
